T1	Participants 977 1068	Eligible patients at National Cholesterol Education Program-Adult Treatment Panel III LDL-C
T2	Participants 875 975	patients with coronary heart disease (CHD) or CHD risk equivalents (clinical trials.gov NCT00685776)
